Steven Cohen's BIO Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 10,195 shares of Bio-Rad Laboratories, Inc. (BIO) worth $2.86 M, representing 0.00% of the portfolio. First purchased in 2015-Q3, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Steven Cohen has maintained a long-term strategic position in BIO, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2024, adding 178,708 shares. Largest reduction occurred in Q1 2025, reducing 212,906 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Bio-Rad Laboratories (BIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bio-Rad Laboratories (BIO) Trades by Steven Cohen
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2015 | +73,700 | New Buy | 73,700 | $134.31 |
| Q4 2015 | -14,900 | Reduce 20.22% | 58,800 | $138.66 |
| Q1 2016 | -58,800 | Sold Out | 58,800 | $0.00 |
| Q2 2016 | +38,800 | New Buy | 38,800 | $143.02 |
| Q3 2016 | -500 | Reduce 1.29% | 38,300 | $163.81 |
| Q4 2016 | -25,600 | Reduce 66.84% | 12,700 | $182.28 |
| Q1 2017 | +81,400 | Add 640.94% | 94,100 | $199.34 |
| Q2 2017 | -94,100 | Sold Out | 94,100 | $0.00 |
| Q1 2018 | +108,200 | New Buy | 108,200 | $250.08 |
| Q2 2018 | -8,597 | Reduce 7.95% | 99,603 | $288.54 |
| Q3 2018 | +30,943 | Add 31.07% | 130,546 | $312.99 |
| Q4 2018 | -4,071 | Reduce 3.12% | 126,475 | $232.22 |
| Q1 2019 | +10,901 | Add 8.62% | 137,376 | $305.68 |
| Q2 2019 | +147,643 | Add 107.47% | 285,019 | $312.59 |
| Q3 2019 | -146,736 | Reduce 51.48% | 138,283 | $332.74 |
| Q4 2019 | -103,441 | Reduce 74.80% | 34,842 | $370.04 |
| Q1 2020 | -34,842 | Sold Out | 34,842 | $0.00 |
| Q2 2020 | +14,305 | New Buy | 14,305 | $451.52 |
| Q3 2020 | -14,305 | Sold Out | 14,305 | $0.00 |
| Q4 2020 | +6,300 | New Buy | 6,300 | $583.02 |
| Q1 2021 | -6,300 | Sold Out | 6,300 | $0.00 |
| Q2 2021 | +11,800 | New Buy | 11,800 | $644.32 |
| Q3 2021 | +23,724 | Add 201.05% | 35,524 | $745.95 |
| Q4 2021 | +43,534 | Add 122.55% | 79,058 | $755.57 |
| Q1 2022 | +36,345 | Add 45.97% | 115,403 | $563.23 |
| Q2 2022 | +26,279 | Add 22.77% | 141,682 | $495.00 |
| Q3 2022 | -52,164 | Reduce 36.82% | 89,518 | $417.15 |
| Q4 2022 | +34,908 | Add 39.00% | 124,426 | $420.49 |
| Q1 2023 | +50,424 | Add 40.53% | 174,850 | $479.02 |
| Q2 2023 | -101,391 | Reduce 57.99% | 73,459 | $379.12 |
| Q3 2023 | -73,459 | Sold Out | 73,459 | $0.00 |
| Q1 2024 | +71,400 | New Buy | 71,400 | $345.87 |
| Q2 2024 | -71,400 | Sold Out | 71,400 | $0.00 |
| Q3 2024 | +250,108 | New Buy | 250,108 | $334.58 |
| Q4 2024 | -2,598 | Reduce 1.04% | 247,510 | $328.51 |
| Q1 2025 | -212,906 | Reduce 86.02% | 34,604 | $243.56 |
| Q2 2025 | -34,604 | Sold Out | 34,604 | $0.00 |
| Q3 2025 | +10,195 | New Buy | 10,195 | $280.39 |
Steven Cohen's Bio-Rad Laboratories Investment FAQs
Steven Cohen first purchased Bio-Rad Laboratories, Inc. (BIO) in Q3 2015, acquiring 73,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Bio-Rad Laboratories, Inc. (BIO) for 41 quarters since Q3 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's largest addition to Bio-Rad Laboratories, Inc. (BIO) was in Q3 2024, adding 250,108 shares worth $83.68 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 10,195 shares of Bio-Rad Laboratories, Inc. (BIO), valued at approximately $2.86 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Bio-Rad Laboratories, Inc. (BIO) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's peak holding in Bio-Rad Laboratories, Inc. (BIO) was 285,019 shares, as reported at the end of Q2 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.